Insightful Understanding of Synergistic Oxygen Reduction on PtCo 3 (111) Toward Zinc-Air Batteries.
Xiangxiong ChenJiangnan GuoDong QianJiayun WuWeixiong LiaoGeoffrey I N WaterhouseJinlong LiuPublished in: Small (Weinheim an der Bergstrasse, Germany) (2024)
Theory-guided materials design is an effective strategy for designing catalysts with high intrinsic activity whilst minimizing the usage of expensive metals like platinum. As proof-of-concept, herein it demonstrates that using density functional theory (DFT) calculations and experimental validation that intermetallic PtCo 3 alloy nanoparticles offer enhanced electrocatatalytic performance for the oxygen reduction reaction (ORR) compared to Pt nanoparticles. DFT calculations established that PtCo 3 (111) surfaces possess better intrinsic ORR activity compared to Pt(111) surfaces, owing to the synergistic action of adjacent Pt and Co active sites which optimizes the binding strength of ORR intermediates to boost overall ORR kinetics. With this understanding, a PtCo 3 /NC catalyst, comprising PtCo 3 nanoparticles exposing predominantly (111) facets dispersed on an N-doped carbon support, is successfully fabricated. PtCo 3 /NC demonstrates a high specific activity (3.4 mA cm -2 mg Pt -1 ), mass activity (0.67 A mg Pt -1 ), and cycling stability for the ORR in 0.1 M KOH, significantly outperforming a commercial 20 wt.% Pt/C catalyst. Moreover, a zinc-air battery (ZAB) assembled with PtCo 3 /NC as the air-electrode catalyst delivered an open-circuit voltage of 1.47 V, a specific capacity of 775.1 mAh g Zn -1 and excellent operation durability after 200 discharge/charge cycles, vastly superior performance to a ZAB built using commercial Pt/C+IrO 2 as the air-electrode catalyst.
Keyphrases
- density functional theory
- highly efficient
- molecular dynamics
- metal organic framework
- ionic liquid
- room temperature
- reduced graphene oxide
- visible light
- molecular dynamics simulations
- carbon dioxide
- cancer therapy
- biofilm formation
- staphylococcus aureus
- climate change
- cystic fibrosis
- health risk
- risk assessment
- solid state
- human health